Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Accuredit Therapeutics and N1 Life Form a Joint Venture Named 'Napoltec', Dedicated to the Development of Therapeutic Drug Delivery Systems and Pressing Ahead Clinical Translation 2022-01-13 13:33
NeuroAiD(TM)II holds promise as a safe add-on therapy to standard Alzheimer Disease symptomatic treatments and may have a disease modifying effect by delaying disease progression 2022-01-13 12:32
Enrollment Completed in Phase II Clinical Study of KN026 Combined with KN046 2022-01-13 10:46
Samsung Biologics Shares Strategic Roadmap for Sustainable Growth at the 40th Annual JP Morgan Healthcare Conference 2022-01-13 08:52
CStone announces phase 2 GEMSTONE-201 trial met primary endpoint of objective response rate (ORR) in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL) 2022-01-13 08:05
Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Development Platform at the 40th Annual J.P. Morgan Healthcare Conference 2022-01-13 04:00
Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 2022-01-13 00:00
I-Mab Announces First Patient Dosed in China Phase 2 Clinical Trial of Efineptakin Alfa in Combination with Pembrolizumab in Advanced Solid Tumors 2022-01-12 21:00
Gracell Biotechnologies Unveils Innovation Center in U.S. 2022-01-12 21:00
South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine 2022-01-12 20:43
Bionomics Limited participated in the H.C Wainwright BioConnect Conference 2022-01-12 19:00
PostEra Closes $24M in New Financing to Advance Drug Discovery 2022-01-11 22:00
Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity 2022-01-11 21:30
Qilian International Holding Group Limited Releases 2022 Chairman Letter 2022-01-11 20:00
Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and Development Collaboration to Jointly Advance Multiple Targets 2022-01-11 16:30
Latest Study Shows Encouraging Results of CanSinoBIO's Inhaled COVID-19 Vaccine as Heterologous Booster 2022-01-11 15:15
SNIPR BIOME Announces FDA Clearance of Investigational New Drug (IND) Application for SNIPR001, a Novel CRISPR Therapy Targeting Life-Threatening E. coli Infections 2022-01-11 14:29
Pfizer Drives Cultural Change in Sustainable and Accessible Data with MicroStrategy 2022-01-11 09:30
Keep Your Home Safe and Build a Protected Community Against Omicron with Circle HealthPod 2022-01-11 09:00
Ascletis Announces First Patient Dosed in the Phase II Clinical Trial of ASC42, An In-House Developed, Best-in-Class FXR Agonist for Chronic Hepatitis B Indication 2022-01-11 08:30
1 202 203 204 205 206 416